Gastroesophageal Reflux Disease (GERD) is no longer just a Western health concern; it has become a global epidemic affecting nearly 20% of the world's population. In 2026, the strategy for managing this burden is centered on "Direct-to-Consumer Empowerment" through the expansion of Over-the-Counter (OTC) PPI availability. By moving trusted brands like Nexium and Prilosec from the prescription...